PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF CREATININE-DRUG INTERACTION IN CHRONIC KIDNEY DISEASE POPULATION.

被引：0
|
作者：
Takita, H. [1 ,2 ]
Scotcher, D. [1 ]
Chinnadurai, R. [3 ]
Kalra, P. [3 ]
Galetin, A. [1 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Asahi Kasei Pharma, Shizuoka, Japan
[3] Salford Royal NHS Fdn Trust, Salford, Lancs, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-130
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [21] In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin
    Mamidi, Rao N. V. S.
    Dallas, Shannon
    Sensenhauser, Carlo
    Lim, Heng Keang
    Scheers, Ellen
    Verboven, Peter
    Cuyckens, Filip
    Leclercq, Laurent
    Evans, David C.
    Kelley, Michael F.
    Johnson, Mark D.
    Snoeys, Jan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (05) : 1082 - 1096
  • [22] APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO BOSUTINIB PHARMACOKINETICS: PREDICTION OF DRUG-DISEASE INTERACTION IN ORGAN DYSFUNCTION PATIENTS.
    Ono, C.
    Hsyu, P.
    Abbas, R.
    Loi, C.
    Yamazaki, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S74 - S74
  • [23] Physiologically-Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and Samidorphan
    Sun, Lei
    von Moltke, Lisa
    Yeo, Karen Rowland
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (02): : 106 - 114
  • [24] Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling to Assess Drug Interaction Potential of Antibody-Drug Conjugates (ADCs)
    Samineni, Divya
    Chen, Yuan
    Mukadam, Sophie
    Wong, Harvey
    Shen, Ben-Quan
    Lu, Dan
    Hop, Cornelis
    Girish, Sandhya
    Li, Chunze
    Jin, Jin Yan
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S91 - S91
  • [25] A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator
    Curry, Liam
    Alrubia, Sarah
    Bois, Frederic Y.
    Clayton, Ruth
    El-Khateeb, Eman
    Johnson, Trevor N.
    Faisal, Muhammad
    Neuhoff, Sibylle
    Wragg, Kris
    Rostami-Hodjegan, Amin
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (09): : 1429 - 1447
  • [26] A physiologically-based pharmacokinetic model of drug detoxification by nanoparticles
    Fallon, MS
    Varshney, M
    Dennis, DM
    Chauhan, A
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2004, 31 (05) : 381 - 400
  • [27] Response to in vitro and physiologically-based pharmacokinetic assessment of the drug-drug interaction potential of canagliflozin
    Miners, John O.
    Pattanawongsa, Attarat
    Rowland, Andrew
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (02) : 392 - 393
  • [28] Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles
    Deng, Linjing
    Liu, Hui
    Ma, Yongsheng
    Miao, Yufeng
    Fu, Xiaoli
    Deng, Qihong
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 384
  • [29] A Physiologically-Based Pharmacokinetic Model of Drug Detoxification by Nanoparticles
    Marissa S. Fallon
    Manoj Varshney
    Donn M. Dennis
    Anuj Chauhan
    Journal of Pharmacokinetics and Pharmacodynamics, 2004, 31 : 381 - 400
  • [30] Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With Bictegravir
    Stader, Felix
    Battegay, Manuel
    Marzolini, Catia
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1231 - 1239
12345